---
type: "WebPage"
title: "Peptide aggregation analysis laboratory"
description: "As a biopharmaceutical manufacturer, you would like to carry out an analysis of peptide aggregation What is a peptide aggregation? A peptide aggregation is an assembly of several peptide molecules that group together spontaneously or under certain environmental conditions. These aggregates..."
resource: "https://filab.fr/en/sectors-of-activity/biopharmaceutical/peptide-aggregation-analysis-laboratory/"
tags: ["EN", "pll_67adc14826098", "Anaïs DECAUX"]
timestamp: "2026-03-12T08:14:51Z"
published: "2025-02-13T10:17:41Z"
language: "en"
author: "Laure Durieux"
---

# Peptide aggregation analysis laboratory

## As a biopharmaceutical manufacturer, you would like to carry out an analysis of peptide aggregation

### What is a peptide aggregation?

A **peptide aggregation** is an assembly of several peptide molecules that group together spontaneously or under certain environmental conditions. These aggregates can be **reversible** (if the peptides can dissociate) or **irreversible** (stable formation of insoluble aggregates).

### How a peptide aggregation is formed

This phenomenon can be due to various molecular interactions, such as **hydrogen bonds**, **Van der Waals forces or hydrophobic interactions**. Aggregate formation is a major issue in the pharmaceutical and biotechnology industry, as it can affect the **stability, efficacy and safety of peptide formulations**, including by increasing the risk of **immunogenicity**.

Peptide aggregation analysis is therefore crucial to **optimize manufacturing processes, ensure product quality and meet regulatory requirements**.

## FILAB supports biopharmaceutical manufacturers in the analysis of peptide aggregation

### Why choose FILAB?

FILAB laboratory, analytical expertise laboratory, offers analysis services for your peptide aggregations using cutting-edge techniques adapted to industrial constraints and regulatory requirements.

Our experts support you in interpreting the results and optimizing your formulations. Thanks to our expertise in **analysis, expertise and [R&D](https://filab.fr/en/our-services/rd.md)**, we help you solve your specific problems and guarantee the quality of your products.

## Our analysis services

Identification and fine characterization of glycosylated structures

Complementary structural characterization

Characterization of therapeutic [glycoproteins](https://filab.fr/en/sectors-of-activity/biopharmaceutical/biotherapeutic-recombinant-protein-characterization/analysis-characterization-glycoproteins.md), [biosimilars](https://filab.fr/en/sectors-of-activity/biopharmaceutical/biotherapeutic-recombinant-protein-characterization/analysis-characterization-biosimilars.md) and [vaccines](https://filab.fr/en/our-services/our-expertise-services/laboratory-analysis-injectable-drugs/laboratory-for-the-analysis-of-injectable-products-and-pharmaceutical-vaccines.md).

[N-glycans analysis](https://filab.fr/en/sectors-of-activity/biopharmaceutical/n-glycans-analysis.md)

[Protein sequencing analysis](https://filab.fr/en/sectors-of-activity/biopharmaceutical/biotherapeutic-recombinant-protein-characterization/protein-sequencing.md)

Separation and analysis of derivatized glycans

[Glycosylation analysis](https://filab.fr/en/sectors-of-activity/biopharmaceutical/glycosylation-analysis.md)

Study of glycans in bioactive [peptides](https://filab.fr/en/sectors-of-activity/biopharmaceutical/biotherapeutic-recombinant-protein-characterization/peptide-analysis-biopharmaceutical-services.md) and [proteins](https://filab.fr/en/sectors-of-activity/biopharmaceutical/biotherapeutic-recombinant-protein-characterization/protein-analysis.md)

[Intact mass analysis](https://filab.fr/en/sectors-of-activity/biopharmaceutical/intact-mass-analysis-laboratory.md)

## Our technical resources

 [### UPLC](https://filab.fr/en/our-technical-resources/laboratory-analysis-uplc.md) [### LC-MS](https://filab.fr/en/our-technical-resources/altis-lc-msms-analysis.md) [### FTIR](https://filab.fr/en/our-technical-resources/laboratory-analysis-ftir-spectroscopy.md) [### NMR](https://filab.fr/en/our-technical-resources/laboratory-analysis-nmr.md)
## Our FAQ

 Why analyze peptide aggregation?
Peptide aggregation analysis is essential to:

- **Ensure the stability** of [biopharmaceutical](https://filab.fr/en/sectors-of-activity/biopharmaceutical.md) formulations
- **Comply with the regulatory requirements** of health authorities
- **Anticipate immunogenicity risks** related to aggregations
- **Optimize formulation and production processes**

   ![](https://filab.fr/wp-content/uploads/2024/10/nucleotide-2.jpg.png)